Cancer Communications
indexed by SCI
BMC


LETTER TO THE EDITOR
Intercellular communications and metabolic reprogramming as new predictive markers for immunotherapy responses in gastric cancer
Ji-Yong Sung, Jae-Ho Cheong
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 4/9/2022   doi:10.1002/cac2.12285
LETTER TO THE EDITOR
Childhood overweight and risk of obesity-related adult cancer in men
Jimmy Célind, Maria Bygdell, Jari Martikainen, Claes Ohlsson, Jenny M Kindblom
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 4/8/2022   doi:10.1002/cac2.12286
ORIGINAL ARTICLE
The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China
Ziyue Zhou, Huazhen Liu, Yiying Yang, Jingya Zhou, Lidan Zhao, Hua Chen, Yunyun Fei, Wen Zhang, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang, Huaxia Yang, Xuan Zhang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/31/2022   doi:10.1002/cac2.12283
LETTER TO THE EDITOR
ABTL0812 enhances antitumor effect of paclitaxel and reverts chemoresistance in triple-negative breast cancer models
Emma Polonio-Alcalá, Sònia Solé-Sánchez, Pau Mu?oz-Guardiola, Elisabet Megías-Roda, Héctor Perez-Montoyo, Marc Yeste-Velasco, Jose Alfón, Jose Miguel Lizcano, Carles Domènech, Santiago Ruiz-Martínez, Teresa Puig
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/16/2022   doi:10.1002/cac2.12282
ORIGINAL ARTICLE
m6A‐mediated regulation of PBX1‐GCH1 axis promotes gastric cancer proliferation and metastasis by elevating tetrahydrobiopterin levelstetrahydrobiopterin levels
Yinan Liu, Ertao Zhai, Junting Chen, Yan Qian, Risheng Zhao, Yan Ma, Jianqiu Liu, Zhixin Huang, Shirong Cai, Jianhui Chen
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/9/2022   doi:10.1002/cac2.12281
LETTER TO THE EDITOR
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition
Christian Schneeweis, Zonera Hassan, Katja Ascherl, Matthias Wirth, Stella Koutsouli, Felix Orben, Lukas Krau?, Carolin Schneider, Rupert ?llinger, Oliver H. Kr?mer, Roland Rad, Maximilian Reichert, Maria S. Robles, Dieter Saur, Günter Schneider
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/7/2022   doi:10.1002/cac2.12280
LETTER TO THE EDITOR
Matrisomal genes in squamous cell carcinoma of head and neck influence tumor cell motility and response to cetuximab treatment
Kah Yee Goh, Kah Weng Lau, Terence You De Cheng, Su Chin Tham, Chwee Teck Lim, Narayanan Gopalakrishna Iyer, Su Bin Lim, Darren Wan-Teck Lim
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/2/2022   doi:10.1002/cac2.12279
ORIGINAL ARTICLE
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
Ziliang Wang, Wei Chen, Ling Zuo, Midie Xu, Yong Wu, Jiami Huang, Xu Zhang, Yongheng Li, Jing Wang, Jing Chen, Husheng Wang, Huizhen Sun
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 3/2/2022   doi:10.1002/cac2.12274
ORIGINAL ARTICLE
XELOX doublet regimen versus EOX triplet regimen as first‐line treatment for advanced gastric cancer: An open‐labeled, multicenter, randomized, prospective phase III trial (EXELOX)
Xiao-Dong Zhu, Ming-Zhu Huang, Yu-Sheng Wang, Wan-Jing Feng, Zhi-Yu Chen, Yi-Fu He, Xiao-Wei Zhang, Xin Liu, Chen-Chen Wang, Wen Zhang, Jie-Er Ying, Jun Wu, Lei Yang, Yan-Ru Qin, Jian-Feng Luo, Xiao-Ying Zhao, Wen-Hua Li, Zhe Zhang, Li-Xin Qiu, Qi-Rong Ge
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/25/2022   doi:10.1002/cac2.12278
ORIGINAL ARTICLE
Phosphatidylserine released from apoptotic cells in tumor induces M2‐like macrophage polarization through the PSR‐STAT3‐JMJD3 axis
Xiao Liang, Min Luo, Bin Shao, Jing-Yun Yang, An Tong, Rui-Bo Wang, Yan-Tong Liu, Ren Jun, Ting Liu, Tao Yi, Xia Zhao, Yu-Quan Wei, Xia-Wei Wei
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 2/22/2022   doi:10.1002/cac2.12272

<<    Page 36 of 81  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China